Your browser doesn't support javascript.
loading
Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome: A Randomized Clinical Trial.
Wu, Xiao-Ke; Stener-Victorin, Elisabet; Kuang, Hong-Ying; Ma, Hong-Li; Gao, Jing-Shu; Xie, Liang-Zhen; Hou, Li-Hui; Hu, Zhen-Xing; Shao, Xiao-Guang; Ge, Jun; Zhang, Jin-Feng; Xue, Hui-Ying; Xu, Xiao-Feng; Liang, Rui-Ning; Ma, Hong-Xia; Yang, Hong-Wei; Li, Wei-Li; Huang, Dong-Mei; Sun, Yun; Hao, Cui-Fang; Du, Shao-Min; Yang, Zheng-Wang; Wang, Xin; Yan, Ying; Chen, Xiu-Hua; Fu, Ping; Ding, Cai-Fei; Gao, Ya-Qin; Zhou, Zhong-Ming; Wang, Chi Chiu; Wu, Tai-Xiang; Liu, Jian-Ping; Ng, Ernest H Y; Legro, Richard S; Zhang, Heping.
Afiliação
  • Wu XK; Committee of Reproductive Medicine, World Federation of Chinese Medicine Societies, Beijing, China2Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Stener-Victorin E; Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China3Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Kuang HY; Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Ma HL; Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Gao JS; Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Xie LZ; Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Hou LH; Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Hu ZX; Outpatient Department, Xuzhou Maternal and Children's Hospital, Xuzhou, China.
  • Shao XG; Centre for Reproductive Medicine, Dalian Maternal and Children's Centre, Dalian, China.
  • Ge J; Department of Infertility, Tanggu District Maternal and Children's Hospital, Tianjin, China.
  • Zhang JF; Department of Obstetrics and Gynecology, Shanxi Province Hospital of Chinese Medicine, Taiyuan, China.
  • Xue HY; Centre for Reproductive Medicine, Huaian Maternal and Children's Hospital, Huaian, China.
  • Xu XF; Department of Gynecology, Suzhou City Hospital of Chinese Medicine, Suzhou, China.
  • Liang RN; Department of Gynecology, Second Hospital, Jiangxi University of Chinese Medicine, Nanchang, China.
  • Ma HX; Department of Chinese Medicine, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Yang HW; Department of Infertility, Liwan District Hospital of Chinese Medicine, Guangzhou, China.
  • Li WL; Department of Obstetrics and Gynecology, Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, China.
  • Huang DM; Institute of Integrated Traditional and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Sun Y; Department of Gynecology, Wenzhou City Hospital of Chinese Medicine, Wenzhou, China.
  • Hao CF; Centre for Reproductive Medicine, Yuhuangding Hospital, Yantai, China.
  • Du SM; Department of Obstetrics and Gynecology, Daqing Longnan Hospital, Daqing, China.
  • Yang ZW; Department of Obstetrics and Gynecology, First Affiliated Hospital, Hunan University of Chinese Medicine, Changsha, China.
  • Wang X; Department of Obstetrics and Gynecology, First Affiliated Hospital, Liaoning University of Chinese Medicine, Shenyang, China.
  • Yan Y; Department of Gynecology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Chen XH; Department of Traditional Technology, Guangdong Province Hospital of Chinese Medicine, Guangzhou, China.
  • Fu P; Department of Gynecology, Hangzhou City Hospital of Chinese Medicine, Hangzhou, China.
  • Ding CF; Centre for Reproductive Medicine, Zhejiang Province Hospital of Integrative Medicine, Hangzhou, China.
  • Gao YQ; Centre for Reproductive Medicine, Daqing Oilfield General Hospital, Daqing, China.
  • Zhou ZM; Department of Obstetrics and Gynecology, Hubei Province Hospital of Chinese Medicine, Wuhan, China.
  • Wang CC; Department of Obstetrics and Gynecology, The Chinese University of Hong Kong, Hong Kong, China27Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China28School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China.
  • Wu TX; Chinese Clinical Trial Registry, Shenzhen, China.
  • Liu JP; Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
  • Ng EHY; Department of Obstetrics and Gynecology, The University of Hong Kong, Hong Kong, China.
  • Legro RS; Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China32Department of Obstetrics and Gynecology, Pennsylvania State University, Hershey.
  • Zhang H; Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut.
JAMA ; 317(24): 2502-2514, 2017 06 27.
Article em En | MEDLINE | ID: mdl-28655015
ABSTRACT
Importance Acupuncture is used to induce ovulation in some women with polycystic ovary syndrome, without supporting clinical evidence.

Objective:

To assess whether active acupuncture, either alone or combined with clomiphene, increases the likelihood of live births among women with polycystic ovary syndrome. Design, Setting, and

Participants:

A double-blind (clomiphene vs placebo), single-blind (active vs control acupuncture) factorial trial was conducted at 21 sites (27 hospitals) in mainland China between July 6, 2012, and November 18, 2014, with 10 months of pregnancy follow-up until October 7, 2015. Chinese women with polycystic ovary syndrome were randomized in a 1111 ratio to 4 groups.

Interventions:

Active or control acupuncture administered twice a week for 30 minutes per treatment and clomiphene or placebo administered for 5 days per cycle, for up to 4 cycles. The active acupuncture group received deep needle insertion with combined manual and low-frequency electrical stimulation; the control acupuncture group received superficial needle insertion, no manual stimulation, and mock electricity. Main Outcomes and

Measures:

The primary outcome was live birth. Secondary outcomes included adverse events.

Results:

Among the 1000 randomized women (mean [SD] age, 27.9 [3.3] years; mean [SD] body mass index, 24.2 [4.3]), 250 were randomized to each group; a total of 926 women (92.6%) completed the trial. Live births occurred in 69 of 235 women (29.4%) in the active acupuncture plus clomiphene group, 66 of 236 (28.0%) in the control acupuncture plus clomiphene group, 31 of 223 (13.9%) in the active acupuncture plus placebo group, and 39 of 232 (16.8%) in the control acupuncture plus placebo group. There was no significant interaction between active acupuncture and clomiphene (P = .39), so main effects were evaluated. The live birth rate was significantly higher in the women treated with clomiphene than with placebo (135 of 471 [28.7%] vs 70 of 455 [15.4%], respectively; difference, 13.3%; 95% CI, 8.0% to 18.5%) and not significantly different between women treated with active vs control acupuncture (100 of 458 [21.8%] vs 105 of 468 [22.4%], respectively; difference, -0.6%; 95% CI, -5.9% to 4.7%). Diarrhea and bruising were more common in patients receiving active acupuncture than control acupuncture (diarrhea 25 of 500 [5.0%] vs 8 of 500 [1.6%], respectively; difference, 3.4%; 95% CI, 1.2% to 5.6%; bruising 37 of 500 [7.4%] vs 9 of 500 [1.8%], respectively; difference, 5.6%; 95% CI, 3.0% to 8.2%). Conclusions and Relevance Among Chinese women with polycystic ovary syndrome, the use of acupuncture with or without clomiphene, compared with control acupuncture and placebo, did not increase live births. This finding does not support acupuncture as an infertility treatment in such women. Trial Registration clinicaltrials.gov Identifier NCT01573858.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome do Ovário Policístico / Terapia por Acupuntura / Clomifeno / Nascido Vivo / Fármacos para a Fertilidade Feminina / Infertilidade Feminina Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Revista: JAMA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome do Ovário Policístico / Terapia por Acupuntura / Clomifeno / Nascido Vivo / Fármacos para a Fertilidade Feminina / Infertilidade Feminina Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Revista: JAMA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China